These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 4301560)

  • 1. [Antacid effect of a magnesium trisilicate-1-hyoscyamine combination preparation (Neoplex B)--clinical and function analytical studies].
    Piaty R
    Wien Med Wochenschr; 1968 Feb; 118(8):157-9. PubMed ID: 4301560
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ulfon in the treatment of gastroduodenal ulcer].
    Tournerie J
    J Med Bord; 1965 May; 142(5):853-8. PubMed ID: 5830454
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of 1-hyoscyamine on gastric secretion of acid and pepsin in man.
    Walan A
    Scand J Gastroenterol; 1969; 4(2):157-67. PubMed ID: 4899828
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on peptic ulcer disease with special reference to the effect of l-hyoscyamine.
    Walan A
    Acta Med Scand Suppl; 1970; 516():1-57. PubMed ID: 5293126
    [No Abstract]   [Full Text] [Related]  

  • 5. [On drug therapy of gastric diseases].
    Zylmann E
    Landarzt; 1966 Dec; 42(34):1545-6. PubMed ID: 5980509
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of 1-hyoscyamine on pentagastrin-induced secretion of acid and pepsin in man.
    Walan A; Dotevall G
    Scand J Gastroenterol; 1970; 5(2):135-42. PubMed ID: 4914163
    [No Abstract]   [Full Text] [Related]  

  • 7. Antacids in the treatment of peptic ulcer.
    Dotevall G; Walan A
    Acta Med Scand; 1967 Nov; 182(5):529-37. PubMed ID: 6072623
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new cicatrizing, antivagal and antacid association in the therapy of gastroduodenal ulcer].
    Falcone F
    Minerva Med; 1969 Feb; 60(17):738-44. PubMed ID: 4887321
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of peptic ulcer.
    Siurala M; Salmi H; Jussila J; Reissell P; Perttala Y; Haavisto J
    Med Chir Dig; 1973; 2(3):139-43. PubMed ID: 4595016
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of 1-hyoscyamine in tablets with sustained release on gastric secretion of acid in man.
    Dotevall G; Walan A
    Acta Med Scand; 1965 Dec; 178(6):759-64. PubMed ID: 5322886
    [No Abstract]   [Full Text] [Related]  

  • 11. Anisotropine methylbromide for relief of gastrointestinal spasm: double-blind crossover comparison study with belladonna alkaloids and phenobarbital.
    King JC
    Curr Ther Res Clin Exp; 1966 Nov; 8(11):535-41. PubMed ID: 4962781
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Nilacid treatment in ulcer.
    Figus AI; Papp I; Bajza Y
    Ther Hung; 1986; 34(1):54-6. PubMed ID: 2833824
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled trial of glycopyrronium and l-hyoscyamine in the long-term treatment of duodenal ulcer.
    Kaye MD; Rhodes J; Beck P; Sweetnam PM; Davies GT; Evans KT
    Gut; 1970 Jul; 11(7):559-66. PubMed ID: 4916211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy. Antacid therapy.
    Morrissey JF; Barreras RF
    N Engl J Med; 1974 Mar; 290(10):550-4. PubMed ID: 4359481
    [No Abstract]   [Full Text] [Related]  

  • 15. Gastric secretory patterns before and during treatment with 1-hyoscyamine.
    Christiansen PM; Rodbro P
    Scand J Gastroenterol; 1967; 2(4):251-6. PubMed ID: 4865175
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled verification of the usefulness of Ketoscilium in gastroenterology].
    Alberto S; Pinna G; Frigerio G
    Minerva Med; 1971 Feb; 62(17):852-6. PubMed ID: 5551774
    [No Abstract]   [Full Text] [Related]  

  • 17. [Controlled clinical study of the oral use of Ketoscilium in dyskinetic-spastic disorders of the digestive tract].
    Maduli S; Frigerio G
    Minerva Gastroenterol; 1970; 16(2):94-8. PubMed ID: 5477402
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trials of an association of a choleretic (1-morpholinoacetyl-3-phenyl-4-oxo-1,2,3,4-tetrahydroquinazoline hydrochloride), (Rec 14-0127) and phenolphthalein and belladonna extract].
    Pozzi M
    Farmaco Prat; 1969 Oct; 24(10):655-62. PubMed ID: 4902987
    [No Abstract]   [Full Text] [Related]  

  • 19. [New therapeutic developments in gastroenterology].
    Lebreton JM
    Maroc Med; 1975 Jun; 55(591):335-7. PubMed ID: 1177517
    [No Abstract]   [Full Text] [Related]  

  • 20. [Controlled clinical research on ketoscilium, a new parasympatholytic].
    Chiarioni T; Mancini L
    Clin Ter; 1969 Feb; 48(4):319-40. PubMed ID: 5355891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.